Cargando…
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118034/ https://www.ncbi.nlm.nih.gov/pubmed/35032364 http://dx.doi.org/10.1002/cac2.12260 |
| _version_ | 1784710434094317568 |
|---|---|
| author | Nie, Jiali Yang, Li Huang, Liang Gao, Lili Young, Ken He Le Grange, Jehane Michael Yang, Xingcheng Wei, Jia Xiao, Min Zhou, Jianfeng |
| author_facet | Nie, Jiali Yang, Li Huang, Liang Gao, Lili Young, Ken He Le Grange, Jehane Michael Yang, Xingcheng Wei, Jia Xiao, Min Zhou, Jianfeng |
| author_sort | Nie, Jiali |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9118034 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91180342022-05-20 Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) Nie, Jiali Yang, Li Huang, Liang Gao, Lili Young, Ken He Le Grange, Jehane Michael Yang, Xingcheng Wei, Jia Xiao, Min Zhou, Jianfeng Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-01-15 /pmc/articles/PMC9118034/ /pubmed/35032364 http://dx.doi.org/10.1002/cac2.12260 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Nie, Jiali Yang, Li Huang, Liang Gao, Lili Young, Ken He Le Grange, Jehane Michael Yang, Xingcheng Wei, Jia Xiao, Min Zhou, Jianfeng Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) |
| title | Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) |
| title_full | Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) |
| title_fullStr | Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) |
| title_full_unstemmed | Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) |
| title_short | Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS) |
| title_sort | infection complications in febrile chimeric antigen receptor (car)‐t recipients during the peri‐car‐t cell treatment period examined using metagenomic next‐generation sequencing (mngs) |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118034/ https://www.ncbi.nlm.nih.gov/pubmed/35032364 http://dx.doi.org/10.1002/cac2.12260 |
| work_keys_str_mv | AT niejiali infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT yangli infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT huangliang infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT gaolili infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT youngkenhe infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT legrangejehanemichael infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT yangxingcheng infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT weijia infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT xiaomin infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs AT zhoujianfeng infectioncomplicationsinfebrilechimericantigenreceptorcartrecipientsduringthepericartcelltreatmentperiodexaminedusingmetagenomicnextgenerationsequencingmngs |